Plasmonica Bio was founded to radically improve the probability of success for neurotherapeutics in clinical trials. In pioneering electro-plasmonic sensing, the Plasmonica team is able to record large populations of electrically active cells in vitro with subcellular resolution and high-throughput capacity. By introducing groundbreaking new assays based on electro-plasmonics, Plasmonica produces the most advanced functional electrophysiology screening data in the world.
We soon discovered that our technology has game changing applications for other fields of biology. By measuring fast, high-resolution behavioral dynamics across large cell populations, Plasmonica provides more predictive insight for disease models and potential therapeutics.